SCHEMBL21508366

SCHEMBL21508366

COc1ccc(-c2ccc(C(C)C)cc2)cc1F

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP17A1 P05093 1/20 0.53
FFAR1 O14842 1/20 0.52
PDGFRB P09619 1/20 0.48
PDGFRA P16234 1/20 0.48
TDP2 O95551 1/20 0.47
ERN1 O75460 3/20 0.47
MEN1 O00255 2/20 0.45
ALDH1A1 P00352 2/20 0.45
KMT2A Q03164 2/20 0.45
RAB9A P51151 2/20 0.45
NPC1 O15118 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
PTGS2 P35354 4/20 0.44
PTGS1 P23219 2/20 0.43
NAAA Q02083 2/20 0.43
MAPT P10636 1/20 0.43
LMNA P02545 1/20 0.42
MAPK1 P28482 1/20 0.42
HTT P42858 1/20 0.42
CACNA1H O95180 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL84653 0.85 LMNA (0.47) CYP17A1FFAR1MEN1ALDH1A1KMT2A
SCHEMBL9464193 0.84 CYP17A1 (0.61) CYP17A1PDGFRBPDGFRATDP2ERN1
SCHEMBL12591809 0.84 NAAA (0.43) CYP17A1FFAR1ERN1NAAA
SCHEMBL18713949 0.83 CYP17A1 (0.51) CYP17A1FFAR1PDGFRBPDGFRATDP2
SCHEMBL18713617 0.83 ERN1 (0.54) CYP17A1PDGFRBPDGFRAERN1MEN1
SCHEMBL13906291 0.81 CYP17A1 (0.55) CYP17A1FFAR1PDGFRBPDGFRATDP2
SCHEMBL20032324 0.81 CYP17A1 (0.52) CYP17A1FFAR1PDGFRBPDGFRATDP2
SCHEMBL15605813 0.81 CYP17A1 (0.58) CYP17A1FFAR1PDGFRBPDGFRATDP2
SCHEMBL8481713 0.79 CYP17A1 (0.57) CYP17A1FFAR1PDGFRBPDGFRATDP2
SCHEMBL7783072 0.79 CYP17A1 (0.57) CYP17A1FFAR1PDGFRBPDGFRATDP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3041842-B1 SPIROCYCLIC COMPOUNDS AS TRYPTOPHAN HYDROXYLASE INHIBITORS KAROS PHARMACEUTICALS INC (US) 2019-10-23 EP disclosed